Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies,prevalence of osteoporosis and factors associated with reduced bone density

Abstract

The purpose of this study was to evaluate the clinical characteristics of women with systemic lupus erythematosus (SLE) sent for a dual energy X-ray absorptiometry (DEXA) study, and to analyse the factors associated with a lower bone mineral density in these patients. Women with SLE who had a DEXA done between 1 January 1995 and 31 December 2000 were compared with those who did not have DEXA scans performed. SLE patients with osteoporosis (OP) were compared with those with a normal bone density. Of 516 women with SLE, 205 had a DEXA done. These patients had more traditional risk factors for osteoporosis, higher lupus disease activity, renal involvement, increased damage, higher mean steroid dose, increased use of immunosuppressants and occurrence of avascular necrosis. Of the 205 patients with DEXA, 18% had osteoporosis, 48.8% had osteopenia and 33.2% had normal bone mineral density. The two statistically significant predictors of a low bone density were a higher age at time of DEXA (P ¹/4 0.0003) and a higher SDI score (P ¹/4 0.0019). Osteoporosis is a significant comorbidity in SLE. Lupus patients referred for a DEXA have more traditional risk factors and use more corticosteroids. The main factors associated with a low bone density were however found to be age and increased damage. Interestingly, disease activity and corticosteroid use were not associated with osteoporosis in this study which may suggest other potential causes such as decreased physical activity associated with damage.

Keywords

bone mineral density disease activity osteoporosis prognosis SLE

Get full access to this article

View all access options for this article.

References

Urowitz MB , Gladman DD , Abu-Shakra M , Farewll VT. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years . J Rheumatol 1997; 24: 1061-1065 .

Kalla AA , Fataar AB , Jessop SJ , Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus . Arthritis Rheum 1993; 12: 1726-1734 .

Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update . Arthritis Care Res 1995; 8: 137-145 .

Formiga F , Moga I , Nolla JM et al. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus . Ann Rheum Dis 1995; 54: 274-276 .

Pons F , Peris P , Guanabens N et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in premenopausal women . Br J Rheumatol 1995; 34: 742-746 .

Houssiau FA , Lefebvre C , Depresseux G , Lambert M , Devogelaer JP , Nagant de Deuxchaisnes . Trabecular and cortical bone loss in systemic lupus erythematosus . Br J Rheumatol 1996; 35: 244-247 .

Sels F , Dequeker J , Verwilguen J , Mbuyi-Muamba JM. SLE and osteoporosis; dependence and/or independence on glucocorticoids . Lupus 1996; 5: 89-92 .

Kipen Y , Buchbinder R , Strauss BJG , Strauss B , Littlejohn G , Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of glucocorticoids . J Rheumatol 1997; 24: 1922-1929 .

Kipen Y , Strauss BJG , Morand EF. Body composition in systemic lupus erythematosus . Br J Rheumatol 1998; 37: 514-519 .

10.

Sinigaglia L , Varenna M , Binelli L et al. Determinants of bone mass in systemic lupus erythematosus. A cross-sectional study on premenopausal women . J Rheumatol 1999; 26: 1280-1284 .

11.

Gilboe IM , Kvien TK , Haugeberg G , Husby G. Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls . Ann Rheum Dis 2000; 59: 110-115 .

12.

Redlich K , Ziegler S , Kiener HP et al. Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus . Ann Rheum Dis 2000; 59: 308-310 .

13.

Lakshminarayanan S , Walsh S , Mohanraj M , Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus . J Rheumatol 2001; 28: 102-108 .

14.

Becker A , Fischer R , Scherbaum WA , Schneider M. Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage . Lupus 2001; 10: 809-814 .

15.

Bhattoa HP , Bettembuk P , Balogh A , Szegedi G , Kiss E. Bone mineral density in women with systemic lupus erythematosus . Clin Rheumatol 2002; 21: 135-141 .

16.

Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis . J Clin Endocrinol Metab 1996; 51: 3441-3447 .

17.

Weinstein RS , Jilka RL , Parfitt M , Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids . J Clin Invest 1998; 102: 274-282 .

18.

Vidal NO , Brandstrom H , Jonsson KB , Ohlsson C. Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells; down regulation by glucocorticoids . J Endocrinol 1998; 159: 191-195 .

19.

Kipen Y , Briganti E , Strauss B. Will R , Littlejohn G , Morand E. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus . J Rheumatol 1999; 26: 310-317 .

20.

Zonana-Nacach A , Barr SG , Magder LS , Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids . Arthritis Rheum 2000; 43: 1801-1808 .

21.

Jardinet D , Lefèbvre C , Depresseux G , Lambert M , Devogelaer JP , Houssiau FA. Longitudinal analysis of bone mineral density in premenopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine . Rheumatology 2000; 39: 389-392 .

22.

Li EK , Tam LS , Young RP , Ko GT , Li M , Lau EM. Loss of bone mineral density in Chinese premenopausal women with systemic lupus erythematosus treated with corticosteroids . Br J Rheumatol 1998; 37: 405-410 .

23.

Dhillon VB , Davies MC , Hall ML et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x-ray absorptiometry . Ann Rheum Dis 1990; 49: 624-626 .

24.

Becker A , Heinrich A , Schneider Duesseldorf M. Bone density in systemic lupus erythematosus: a longitudinal study . Arthritis Rheum 2001; 44 (suppl): s260-s260 .

25.

Gordon C , Crabtree N , Skan J , Bowman S , Stonayake D. Prevalence and predictors of osteoporotic fractures in patients with systemic lupus erythematosus . Arthritis Rheum 2001; 44(suppl 9): s334-s334 .

26.

Teichmann J , Lange U , Stracke H , Federlin K , Bretzel RG. Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis . Rheumatol Int 1999; 18: 137-140 .

27.

Gladman DD , Urowitz MB. Systemic lupus erythematosus - clinical features. In Klippel JH , Dieppe PA eds. Rheumatology St Louis Mosby, 2nd edition, 1998; 7: 1.1-1.18.

28.

Brown JP , Josse RG. Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada . Canadian Medical Association Journal 2002; 167: S1-S34 .

29.

Gladman DD , Ibañez D , Urowitz MB. SLE Disease Activity Index 2000 . J Rheumatol 2002; 29: 288-291 .

30.

Ibañez D , Urowitz MB , Gladman DD. Disease activity over time - the adjusted mean SLEDAI . J Rheumatol 2003; 30: 1977-1982 .

31.

Gladman DD , Ginzler E , Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus . Arthritis Rheum 1996; 39: 363-369 .

32.

Maddison P , Farewell V , Isenberg D et al. The rate and pattern of organ damage in late onset systemic lupus erythematosus . J Rheumatol 2002; 29: 913-917 .

33.

Pocock N , Eisman J , Yates M , Sambrook PN , Eberl S. Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density . J Clin Invest 1986; 78: 618-621 .